Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-20-004916
Filing Date
2020-03-27
Accepted
2020-03-27 16:31:29
Documents
87
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1052722
2 ex4-1.htm EX-4.1 18289
3 ex21-1.htm EX-21.1 3677
4 ex23-1.htm EX-23.1 4778
5 ex31-1.htm EX-31.1 8108
6 ex31-2.htm EX-31.2 11913
7 ex32-1.htm EX-32.1 12971
  Complete submission text file 0001493152-20-004916.txt   4824028

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE cocp-20191231.xml EX-101.INS 681004
9 XBRL SCHEMA FILE cocp-20191231.xsd EX-101.SCH 59848
10 XBRL CALCULATION FILE cocp-20191231_cal.xml EX-101.CAL 69517
11 XBRL DEFINITION FILE cocp-20191231_def.xml EX-101.DEF 224442
12 XBRL LABEL FILE cocp-20191231_lab.xml EX-101.LAB 399578
13 XBRL PRESENTATION FILE cocp-20191231_pre.xml EX-101.PRE 343582
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38418 | Film No.: 20752233
SIC: 2834 Pharmaceutical Preparations